GALT
Galectin Therapeutics Inc.
$5.07
+$0.35(+7.42%)
45
Overall
40
Value
66
Tech
31
Quality
Market Cap
$307.49M
Volume
470.95K
52W Range
$0.73 - $6.55
Target Price
$6.00
Key Metrics Overview
| Market Cap | $307.49M | P/E Ratio | N/A |
| 52W High | $6.55 | 52W Low | $0.73 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 74.6% |
| Overall Score | 45 | Value Score | 40 |
| Quality Score | 31 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-0.49 | EPS Next Est | $-0.44 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GALT | $5.07 | +7.4% | 470.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Galectin Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW